EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.1.2.2 | Adenocarcinoma |
6103716 |
Medium chain fatty acid synthesis in rodent mammary adenocarcinomas in vitro. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
2
1
1
0 |
| 3.1.2.2 | Adenocarcinoma |
29555575 |
ACOT1 expression is associated with poor prognosis in gastric adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 3.1.2.2 | Alzheimer Disease |
22155432 |
Putting proteins in their place: Palmitoylation in Huntington disease and other neuropsychiatric diseases. |
unassigned |
0 |
| 3.1.2.2 | Atherosclerosis |
28416579 |
Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (?C20)-acyl chains in macrophages. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
3
1
0 |
| 3.1.2.2 | Breast Neoplasms |
3524817 |
Evaluation of thioesterase II as a serum marker for rat mammary cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
2
4 |
| 3.1.2.2 | Breast Neoplasms |
28518146 |
Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKC?-p53-p21 signaling pathway. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
1 |
| 3.1.2.2 | Breast Neoplasms |
31300609 |
An Inhibitor of Fatty Acid Synthase Thioesterase Domain with Improved Cytotoxicity against Breast Cancer Cells and Stability in Plasma. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
3
0 |
| 3.1.2.2 | Carcinogenesis |
8933048 |
The NIEHS Predictive-Toxicology Evaluation Project. |
therapeutic application
unassigned |
1
0 |
| 3.1.2.2 | Carcinoma |
6589427 |
Thioesterase II, a new marker enzyme for human cells of breast epithelial origin. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
4
2 |
| 3.1.2.2 | Carcinoma |
28518146 |
Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKC?-p53-p21 signaling pathway. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
1 |
